Direct effects of canagliflozin on human myocardial redox signalling: a novel role for SGLT1 inhibition (2020)
Attributed to:
The predictive value of molecular and imaging markers for future cardiovascular events and outcomes
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/ehjci/ehaa946.3351
Publication URI: http://dx.doi.org/10.1093/ehjci/ehaa946.3351
Type: Journal Article/Review
Parent Publication: European Heart Journal
Issue: Supplement_2